The HIF/VEGF signaling pathway can be activated simultaneously in both tumor cells and cancer-associated immune cells, providing advantageous conditions for tumor cells to intravasate and invade distant sites and for cancer-associated immune cells to circulate more effectively in situ [156,157]. This evidence concerns the gene VEGFA and neoplasm.